This review assessed the effectiveness of ways to expand the coverage of existing immunisation services in developing countries. The authors concluded that all interventions bar one had a positive impact, but firm conclusions could not be drawn because of the paucity and limitations of the primary studies. These conclusions appear appropriate.
in measurement and selection, confounding, and the precision of the results. In addition, the external validity of the studies was assessed according to whether a clear and comprehensive description of the intervention context was given, and whether the authors were transparent in their assumptions and directly considered issues of generalisability. Each dimension of study quality was scored adequate, partial, inadequate or unknown. Only effectiveness studies with four or less limitations were included in the analysis. The authors did not state how many reviewers performed the validity assessment.
Data extraction
The authors did not state how the data were extracted for the review, or how many reviewers performed the data extraction. The percentage of FVC was extracted.
Methods of synthesis How were the studies combined?
The results from the studies were tabulated and combined in a narrative.
How were differences between studies investigated?
The correlation between the impact of the interventions and the rates of immunisation at baseline was assessed.
Results of the review
Fifty-two studies were included in the effectiveness evaluation; the results were based on the 21 studies with four or less methodological limitations. The study designs were not reported.
In terms of study quality, confounding was present in 37% of the studies and unknown in 51%. Only 16% of the papers reported confidence intervals. Follow-up was often partial or inadequate. Few studies defined the data sources.
The mean rate of immunisation at baseline was 34% (standard deviation, SD, 19%; minimum 3%, maximum 65%). Across the studies the mean increase in the proportion of FVC was 27% (SD 19%; minimum -1%, maximum 72%). With the exception of one study, which evaluated an immunisation campaign in Cameroon, all of the interventions had a positive impact. The interventions with the highest impact on full coverage were community health workers and channelling. There was no significant association between the rate of immunisation at baseline and the size of the improvement in the percentage of FVC across the studies. Neither was it observed that any one category of intervention (supply, demand, demand and supply) was associated with significantly better beneficial increases in rates across the studies.
Cost information
Yes. In three countries the average dose of vaccine delivered, per dose of DPT3 and per FVC was higher for campaigns than for routine services. There was a wide variation in cost, ranging from US$7 to US$222 (based on US$ exchange rates for 2001). Outreach teams had a higher average cost than mass campaigns and routine programmes, but were equally or less expensive than fixed centres in Brazil. In Kenya, it was found that the cost for mobile health teams were lower where the population density was higher, and vice versa. In the Amazon region of Ecuador, the cost of an outreach strategy conducted with the involvement of community health workers was less then that for an outreach strategy conducted by hospital staff alone. The strategies that showed the lowest average incremental cost per FVC were peer training and channelling.
